Skip to main content
. Author manuscript; available in PMC: 2012 Dec 4.
Published in final edited form as: Expert Opin Biol Ther. 2011 Aug 28;11(11):1409–1418. doi: 10.1517/14712598.2011.615741

Table 2.

Target lesions for patients enrolled demonstrate large tumor burden.

Patient # Lesion number (location) Baseline size by RECIST (cm)
1 1 (liver) 3.8
2 (liver) 3.1
2 1 (liver) 3.7
2 (liver) 1.6
3 (liver) 1.6
3 1 (liver) 1.5
2 (liver) 1.0
4 1 (liver) 8.0
2 (liver) 2.7
5 1 (liver) 8.5
2 (liver) 2.2
6 1 (liver) 2.2
2 (lung) 6.2
7 1 (liver) 3.5
2 (liver) 2.2
8 1 (liver) 2.5
2 (liver) 2.3
3 (lymph node) 3.3
9* 1 (rectum) 4.5
2 (adrenal gland) 2.2
10 1 (liver) 3.3
2 (liver) 2.5
3 (liver) 2.0
4 (lymph node) 1.7
11 1 (liver) 3.6
2 (liver) 2.3
3 (liver) 2.2
4 (lung) 1.4
12 1 (liver) 3.0
2 (liver) 1.6
*

Patient had metastatic liver lesions not followed as target lesions because they were not > 1 cm.